Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cario

Showing results (521-530 of 548) with videos related to

Pageof 55
Sort By:
Bone Marrow Transplantation|May 16, 2019
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALLFlorian Babor, Christina Peters, Angela R Manser, et al.
Blood|December 28, 2023
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALLLorenz Bastian, Thomas Beder, Malwine J Barz, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.
Hemasphere|April 20, 2026
Biological and clinical characteristics of <i>ETV6</i>::<i>RUNX1</i>-like ALLMarketa Zaliova, Dagmar Schinnerl, Judith M Boer, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Pediatric Blood & Cancer|December 24, 2019
Sickle cell disease in Germany: Results from a national registryJoachim B Kunz, Stephan Lobitz, Regine Grosse, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
Blood Advances|August 28, 2020
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALLBeat Bornhauser, Gunnar Cario, Anna Rinaldi, et al.
Pageof 55

Showing results (521-530 of 548) with videos related to

Sort By:
Pageof 55
Bone Marrow Transplantation|May 16, 2019
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALLFlorian Babor, Christina Peters, Angela R Manser, et al.
Blood|December 28, 2023
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALLLorenz Bastian, Thomas Beder, Malwine J Barz, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.
Hemasphere|April 20, 2026
Biological and clinical characteristics of <i>ETV6</i>::<i>RUNX1</i>-like ALLMarketa Zaliova, Dagmar Schinnerl, Judith M Boer, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Pediatric Blood & Cancer|December 24, 2019
Sickle cell disease in Germany: Results from a national registryJoachim B Kunz, Stephan Lobitz, Regine Grosse, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
Blood Advances|August 28, 2020
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALLBeat Bornhauser, Gunnar Cario, Anna Rinaldi, et al.
Pageof 55